Gelesis’ novel hydrogel GS500 prototype potential treatment for chronic constipation

Gelesis has announced the presentation of data from a clinical study demonstrating that GS500 prototype (GS500/CSP01) provided a significant reduction in colonic transit time (CTT) in patients with chronic idiopathic constipation (CIC) relative to placebo. The data were presented at Digestive Disease Week 2019, held in San Diego, CA.

Looking forward to Dublin 2019: An interview with ESCP President, Per Nilsson

In a series of interviews, we will be previewing this year’s ACPGBI annual meeting in Dublin, 1-3 July. We talked to Dr Per Nilsson, Consultant Colorectal Surgeon and Senior Lecturer at Karolinska University Hospital, Sweden and current President of the European Society of Coloproctology, who discussed the benefits and current evidence for ‘Watch and wait’ and surgery for regrowth after neoadjuvant radiotherapy for rectal cancer.